Search alternatives:
significant drug » significant group (Expand Search), significant degs (Expand Search), significant cause (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
drug increased » drugs increased (Expand Search), from increased (Expand Search), dm increased (Expand Search)
Showing 1 - 20 results of 14,477 for search '(( significant drug increased ) OR ( significant ((facies decrease) OR (largest decrease)) ))', query time: 0.73s Refine Results
  1. 1
    Statistically significant linear increase in use of antidepressants during the observed time period.

    Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Decrease of injuries.

    Decrease of injuries. by Petr Fulin (8380320)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 3
    Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period.

    Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Choosing cardiotoxic drug concentrations that elicited a change in metabolism without a significant increase in cell death.

    Choosing cardiotoxic drug concentrations that elicited a change in metabolism without a significant increase in cell death. by Bonnie V. Dougherty (8721621)

    Published 2024
    Save to List
    Saved in:
  5. 5
    List of metabolites with significantly increased or decreased accumulation in CSF of dKO vs WT rats.

    List of metabolites with significantly increased or decreased accumulation in CSF of dKO vs WT rats. by Samit Ganguly (1792294)

    Published 2021
    Save to List
    Saved in:
  6. 6
    Decrease of admissions and lead diagnoses.

    Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Brain areas with significant rCBF increase in within-group comparisons in each group.

    Brain areas with significant rCBF increase in within-group comparisons in each group. by Yutaro Mori (3125268)

    Published 2020
    Save to List
    Saved in:
  9. 9
    Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period.

    Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Sensitivity analyses of seroprevalence with the largest sample size study omitted.

    Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

    Published 2024
    Save to List
    Saved in:
  12. 12
    Significant relationships between QOL measures on infusion day and day 7.

    Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    GFR by drug.

    GFR by drug. by Mariana Corrochano (14241644)

    Published 2022
    Save to List
    Saved in:
  14. 14
    Antidiabetic drugs expenditure.

    Antidiabetic drugs expenditure. by Saman Zartab (15842480)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Antidiabetic drug utilization.

    Antidiabetic drug utilization. by Saman Zartab (15842480)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated.

    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 17
    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells.

    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 18
    Baseline characteristics of patients in the uncomplicated phase of COVID-19.

    Baseline characteristics of patients in the uncomplicated phase of COVID-19. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 19
    Biomarkers in uncomplicated patients with CVD/Hypertension.

    Biomarkers in uncomplicated patients with CVD/Hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 20
    Mortality risk in patients with CVD and hypertension.

    Mortality risk in patients with CVD and hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: